22162-22-7 Usage
Uses
Used in Pharmaceutical Industry:
1-Bromo-2,3-dimethyl-5-nitrobenzene and 3-Bromo-5-nitro-o-xylene are used as intermediates in the synthesis of various pharmaceutical compounds. Their unique chemical structures allow for the development of new drugs with specific therapeutic properties.
Used in Agrochemical Industry:
These compounds are also utilized in the production of agrochemicals, such as pesticides and herbicides. Their reactivity and functional groups enable the creation of effective agents for controlling pests and weeds in agricultural settings.
Used in Dye Industry:
1-Bromo-2,3-dimethyl-5-nitrobenzene and 3-Bromo-5-nitro-o-xylene serve as key components in the synthesis of dyes used in various applications, including textiles, plastics, and printing inks. Their presence in dye molecules contributes to the color intensity and stability of the final products.
Used in Organic Synthesis:
Due to their high reactivity, these compounds are valuable building blocks in organic synthesis. They can be further modified or combined with other chemicals to create a wide range of organic compounds for various applications, including the development of new materials and the synthesis of complex organic molecules.
Check Digit Verification of cas no
The CAS Registry Mumber 22162-22-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,2,1,6 and 2 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 22162-22:
(7*2)+(6*2)+(5*1)+(4*6)+(3*2)+(2*2)+(1*2)=67
67 % 10 = 7
So 22162-22-7 is a valid CAS Registry Number.
22162-22-7Relevant academic research and scientific papers
2-CYANOISOINDOLINE DERIVATIVES FOR TREATING CANCER
-
Page/Page column 56, (2017/10/11)
The invention relates to novel compounds of formula I which are inhibitors of deubiquitylating enzymes (DUBs) and/or desumoylating enzymes. In particular, the invention relates to the inhibition of ubiquitin C-terminal hydrolase 7 or ubiquitin specific peptidase 7 (USP7). The invention further relates to methods for the preparation of these compounds and to their use in the treatment of cancer.
